Clinical Trials Browser

Interventional × Ovarian Neoplasms × bemarituzumab × Clear all

NCT07146919 2025-08-28

ANGELICA

Phase 1/2 Not yet recruiting

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms